Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Forbion closes €2.3B fund backed by Eli Lilly, PGGM, and KfW Capital to invest in 30 biotechs.
PRIVATEOct 07, 2026
Amount Raised
€2.3 Billion
Round Type
Venture
West Palm BeachBiotechnologyVenture CapitalLife Science
Investors
KfW CapitalPggmEli Lilly
Description
Forbion has closed a €2.3 billion fund with support from major investors including Eli Lilly, PGGM, and KfW Capital. The fund is dedicated to investing in approximately 30 biotechnology companies. This represents significant backing from both pharma and institutional investors for life sciences innovation. The capital will support Forbion's continued expansion in the biotech investment space.
Company Information
Company
Forbion
Location
West Palm Beach, Florida, United States
About
With approximately €3 billion in assets under management, Forbion provides capital and expertise to life sciences companies, enabling the development of new therapeutics that can impact the future of medicine. Forbion is a leading pan-European venture capital and growth equity firm focused on investing in high-quality life sciences companies across all stages of their development. Forbion Forbion is a dedicated life sciences venture capital firm with offices in The Netherlands, Germany, and Singapore.
Fundz sees it the moment Forbion raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
West Palm BeachBiotechnologyVenture CapitalLife Science